{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T04:02:41Z","timestamp":1772942561175,"version":"3.50.1"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300801"],"award-info":[{"award-number":["82300801"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018607","name":"Henan Province Science and Technology Innovation Talent Program","doi-asserted-by":"publisher","award":["LHGJ20230241"],"award-info":[{"award-number":["LHGJ20230241"]}],"id":[{"id":"10.13039\/501100018607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cytogfr.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:39:32Z","timestamp":1753832372000},"page":"146-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of innate lymphoid cells in kidney disease"],"prefix":"10.1016","volume":"85","author":[{"given":"Qianqian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.cytogfr.2025.07.005_bib1","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.cell.2024.07.010","article-title":"From periphery to center stage: 50 years of advancements in innate immunity","volume":"187","author":"Carpenter","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","article-title":"Development, differentiation, and diversity of innate lymphoid cells","volume":"41","author":"Diefenbach","year":"2014","journal-title":"Immunity"},{"issue":"6237","key":"10.1016\/j.cytogfr.2025.07.005_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science (New York N. Y. )"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.07.005_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","article-title":"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages","volume":"157","author":"Klose","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coi.2018.11.003","article-title":"Cellular pathways in the development of human and murine innate lymphoid cells","volume":"56","author":"Scoville","year":"2019","journal-title":"Curr. Opin. Immunol."},{"issue":"7496","key":"10.1016\/j.cytogfr.2025.07.005_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature13047","article-title":"A committed precursor to innate lymphoid cells","volume":"508","author":"Constantinides","year":"2014","journal-title":"Nature"},{"issue":"7534","key":"10.1016\/j.cytogfr.2025.07.005_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"issue":"6263","key":"10.1016\/j.cytogfr.2025.07.005_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.aac9593","article-title":"Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs","volume":"350","author":"Gasteiger","year":"2015","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.cytogfr.2025.07.005_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.aam5809","article-title":"S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense","volume":"359","author":"Huang","year":"2018","journal-title":"Science (New York N. Y. )"},{"issue":"6731","key":"10.1016\/j.cytogfr.2025.07.005_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.adi3624","article-title":"Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis","volume":"387","author":"\u0160estan","year":"2025","journal-title":"Science"},{"issue":"7752","key":"10.1016\/j.cytogfr.2025.07.005_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","article-title":"Innate lymphoid cells support regulatory t cells in the intestine through interleukin-2","volume":"568","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coi.2015.01.008","article-title":"Role of group 3 innate lymphoid cells in antibody production","volume":"33","author":"Magri","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib15","article-title":"Interleukin-22 from type 3 innate lymphoid cells aggravates lupus nephritis by promoting macrophage infiltration in Lupus-Prone mice","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1311","article-title":"Increased GM-CSF-producing NCR(-) ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease","volume":"10","author":"Chang","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cytogfr.2023.09.002","article-title":"Unravelling the immunobiology of innate lymphoid cells (ILCs): implications in health and disease","volume":"74","author":"Srivastava","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","article-title":"Allergen-experienced group 2 innate lymphoid cells acquire Memory-like properties and enhance allergic lung inflammation","volume":"45","author":"Martinez-Gonzalez","year":"2016","journal-title":"Immunity"},{"issue":"7852","key":"10.1016\/j.cytogfr.2025.07.005_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-021-03188-w","article-title":"Skin-resident innate lymphoid cells converge on a pathogenic effector state","volume":"592","author":"Bielecki","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib20","article-title":"Innate lymphoid cells in autoimmune diseases","volume":"12","author":"Clottu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.1962","article-title":"The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling","volume":"12","author":"Spits","year":"2011","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41423-020-0399-6","article-title":"The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases","volume":"17","author":"Zhou","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ni.3059","article-title":"The brave new world of innate lymphoid cells","volume":"16","author":"Eberl","year":"2015","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","article-title":"Regulatory innate lymphoid cells control innate intestinal inflammation","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12709","article-title":"Deconstructing deployment of the innate immune lymphocyte army for barrier homeostasis and protection","volume":"286","author":"Almeida","year":"2018","journal-title":"Immunol. Rev."},{"issue":"Pt 1","key":"10.1016\/j.cytogfr.2025.07.005_bib28","article-title":"Regulatory roles of transcription factors T-bet and eomes in group 1 ILCs","volume":"143","author":"Liao","year":"2024","journal-title":"Int Immunopharmacol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.07.005_bib29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/eji.201646871","article-title":"Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements","volume":"47","author":"Gabrielli","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2016.07.005","article-title":"Diversity and function of group 1 innate lymphoid cells","volume":"179","author":"Cortez","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2019.11.003","article-title":"Molecular characteristics and possible functions of innate lymphoid cells in the uterus and gut","volume":"52","author":"Tang","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 confer early host protection at initial sites of viral infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.immuni.2020.12.004","article-title":"Group 1 innate lymphoid-cell-derived interferon-\u03b3 maintains anti-viral vigilance in the mucosal epithelium","volume":"54","author":"Shannon","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.07.005_bib34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41590-019-0430-1","article-title":"Mouse cytomegalovirus-experienced ILC1s acquire a memory response dependent on the viral glycoprotein m12","volume":"20","author":"Weizman","year":"2019","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.20051615","article-title":"Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion","volume":"203","author":"Fallon","year":"2006","journal-title":"J. Exp. Med."},{"issue":"7280","key":"10.1016\/j.cytogfr.2025.07.005_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"issue":"7293","key":"10.1016\/j.cytogfr.2025.07.005_bib37","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.cytogfr.2025.07.005_bib38","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.07.005_bib39","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030304","article-title":"Innate lymphoid cells (ILCs): cytokine hubs regulating immunity and tissue homeostasis","volume":"10","author":"Nagasawa","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6169","key":"10.1016\/j.cytogfr.2025.07.005_bib40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1126\/science.1247606","article-title":"Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity","volume":"343","author":"Spencer","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat. Immunol."},{"issue":"13","key":"10.1016\/j.cytogfr.2025.07.005_bib43","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1084\/jem.20130071","article-title":"IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation","volume":"210","author":"Turner","year":"2013","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.07.005_bib44","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jaci.2020.02.026","article-title":"ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation","volume":"145","author":"Leyva-Castillo","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib45","first-page":"23","article-title":"Inflammatory group 2 innate lymphoid cells","volume":"28","author":"Huang","year":"2016","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib46","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/s41598-022-11466-4","article-title":"Dietary antigens suppress the proliferation of type 2 innate lymphoid cells by restraining homeostatic IL-25 production","volume":"12","author":"Lee","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.07.005_bib47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2016.07.043","article-title":"The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome","volume":"166","author":"Gury-BenAri","year":"2016","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.07.005_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00352-22","article-title":"Respiratory influenza virus infection causes dynamic tuft cell and innate lymphoid cell changes in the small intestine","volume":"96","author":"Roach","year":"2022","journal-title":"J. Virol."},{"issue":"34","key":"10.1016\/j.cytogfr.2025.07.005_bib49","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib50","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib51","first-page":"25","article-title":"The origin and role of innate lymphoid cells in the lung","volume":"3","author":"Lai","year":"2016","journal-title":"Mil. Med. Res."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib52","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nm.3892","article-title":"Innate lymphoid cells in the initiation, regulation and resolution of inflammation","volume":"21","author":"Sonnenberg","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.07.005_bib53","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.immuni.2024.04.001","article-title":"Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut","volume":"57","author":"Das","year":"2024","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib54","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.4049\/jimmunol.1001637","article-title":"Immature NK cells, capable of producing IL-22, are present in human uterine mucosa","volume":"185","author":"Male","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib55","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20151403","article-title":"Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation","volume":"212","author":"Song","year":"2015","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-019-0834-9","article-title":"ILC3 in axial spondyloarthritis: the gut angle","volume":"21","author":"Mauro","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.07.005_bib57","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/s41590-023-01612-z","article-title":"Nutrition impact on ILC3 maintenance and function centers on a cell-intrinsic CD71-iron axis","volume":"24","author":"Xiong","year":"2023","journal-title":"Nat. Immunol."},{"issue":"6583","key":"10.1016\/j.cytogfr.2025.07.005_bib58","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1126\/science.aaz8777","article-title":"Trained ILC3 responses promote intestinal defense","volume":"375","author":"Serafini","year":"2022","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41423-023-00975-5","article-title":"PLZF restricts intestinal ILC3 function in gut defense","volume":"20","author":"Xu","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bj.2020.12.003","article-title":"Lymphoid tissue inducer (LTi) cell ontogeny and functioning in embryo and adult","volume":"44","author":"van de Pavert","year":"2021","journal-title":"Biomed. J."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imr.13189","article-title":"Layered origins of lymphoid tissue inducer cells","volume":"315","author":"van de Pavert","year":"2023","journal-title":"Immunol. Rev."},{"issue":"23","key":"10.1016\/j.cytogfr.2025.07.005_bib62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101668118","article-title":"Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity","volume":"118","author":"S\u00e9cca","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib63","first-page":"1","article-title":"Basics of inducible lymphoid organs","volume":"426","author":"Ruddle","year":"2020","journal-title":"Curr. Top. Microbiol Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-019-1500-x","article-title":"Contribution of LTi and T(H)17 cells to b cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis","volume":"16","author":"Schropp","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"14","key":"10.1016\/j.cytogfr.2025.07.005_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147618","article-title":"Innate lymphoid cells in intestinal homeostasis and inflammatory bowel disease","volume":"22","author":"Saez","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.07.005_bib66","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.kint.2020.11.023","article-title":"Innate lymphoid cells in kidney diseases","volume":"99","author":"Wang","year":"2021","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib67","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41422-020-0312-y","article-title":"Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.celrep.2019.06.016","article-title":"Innate lymphoid cells in the induction of obesity","volume":"28","author":"Sasaki","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20161982","article-title":"Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury","volume":"214","author":"Gadani","year":"2017","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108997","article-title":"A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression","volume":"35","author":"Kastenschmidt","year":"2021","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.07.005_bib71","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.it.2020.08.009","article-title":"Tissue-specific features of innate lymphoid cells","volume":"41","author":"Meininger","year":"2020","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.07.005_bib72","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41581-024-00875-5","article-title":"Lymphocytes and innate immune cells in acute kidney injury and repair","volume":"20","author":"Lee","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib73","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e15","article-title":"Bone marrow progenitors and IL-2 signaling contribute to the strain differences of kidney innate lymphoid cells","volume":"23","author":"Ryu","year":"2023","journal-title":"Immune Netw."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2020.00072","article-title":"Innate lymphoid cells in renal inflammation","volume":"11","author":"Becker","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib75","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.kint.2019.07.019","article-title":"Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia\/reperfusion injury","volume":"97","author":"Cao","year":"2020","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib76","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0351","article-title":"Recovery dynamics and prognosis after dialysis for acute kidney injury","volume":"7","author":"Pan","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/path.5242","article-title":"Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury","volume":"248","author":"Cameron","year":"2019","journal-title":"J. Pathol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.07.005_bib78","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1681\/ASN.2016121272","article-title":"IL233, a novel IL-2 and IL-33 hybrid cytokine, ameliorates renal injury","volume":"28","author":"Stremska","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.07.005_bib79","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1681\/ASN.2014050479","article-title":"IL-25 elicits innate lymphoid cells and multipotent progenitor type 2 cells that reduce renal Ischemic\/Reperfusion injury","volume":"26","author":"Huang","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib80","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1681\/ASN.2017070774","article-title":"Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury","volume":"29","author":"Cao","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6056373","article-title":"Regulation of innate lymphoid cells in acute kidney injury: crosstalk between cannabidiol and GILZ","volume":"2020","author":"Baban","year":"2020","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib82","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000747","article-title":"Engineered neuromedin u promotes type 2 innate immunity and renoprotection in acute kidney injury","author":"Trindade-Correia","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"issue":"13","key":"10.1016\/j.cytogfr.2025.07.005_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303276","article-title":"Ultrasmall nanoparticles regulate immune microenvironment by activating IL-33\/ST2 to alleviate renal Ischemia-Reperfusion injury","volume":"13","author":"Xu","year":"2024","journal-title":"Adv. Health Mater."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib84","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1681\/ASN.2016080877","article-title":"IL-33-Mediated expansion of type 2 innate lymphoid cells protects from progressive glomerulosclerosis","volume":"28","author":"Riedel","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib85","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41598-019-39886-9","article-title":"A novel hybrid cytokine IL233 mediates regeneration following Doxorubicin-Induced nephrotoxic injury","volume":"9","author":"Sabapathy","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib86","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2017.06.031","article-title":"Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion","volume":"812","author":"Liang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib87","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1681\/ASN.2010091011","article-title":"IL-33 exacerbates acute kidney injury","volume":"22","author":"Akcay","year":"2011","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041544","article-title":"Emerging roles of Interleukin-33-responsive kidney group 2 innate lymphoid cells in acute kidney injury","volume":"21","author":"Chen","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib89","doi-asserted-by":"crossref","first-page":"F1149","DOI":"10.1152\/ajprenal.00112.2018","article-title":"Impact of cannabidiol treatment on regulatory T-17 cells and neutrophil polarization in acute kidney injury","volume":"315","author":"Baban","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib90","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/jpet.118.251371","article-title":"Glucocorticoid-induced leucine zipper promotes neutrophil and T-Cell polarization with protective effects in acute kidney injury","volume":"367","author":"Baban","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib91","doi-asserted-by":"crossref","first-page":"18237","DOI":"10.1021\/acsnano.1c07270","article-title":"A DNA Nanoraft-Based cytokine delivery platform for alleviation of acute kidney injury","volume":"15","author":"Li","year":"2021","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.07.005_bib92","article-title":"Type 2 innate lymphoid cells are protective against hepatic ischaemia\/reperfusion injury","volume":"5","author":"Cao","year":"2023","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2024.104755","article-title":"Innate lymphoid cells in the brain: focus on ischemic stroke","volume":"157","author":"Mathias","year":"2025","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib94","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3389\/fimmu.2019.00826","article-title":"Group 2 innate lymphoid cells are redundant in experimental renal Ischemia-Reperfusion injury","volume":"10","author":"Cameron","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib95","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-981-13-8871-2_18","article-title":"Inflammatory mediators and renal fibrosis","volume":"1165","author":"Meng","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib96","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1381612825666190319120132","article-title":"Transcriptional characteristics of activated macrophages","volume":"25","author":"Glanz","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.07.005_bib98","doi-asserted-by":"crossref","first-page":"F1501","DOI":"10.1152\/ajprenal.00195.2018","article-title":"Immune cells and inflammation in AKI to CKD progression","volume":"315","author":"Sato","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688647","article-title":"The roles of kidney-resident ILC2 in renal inflammation and fibrosis","volume":"12","author":"Nagashima","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.1901095","article-title":"Expansion of group 2 innate lymphoid cells in patients with end-stage renal disease and their clinical significance","volume":"205","author":"Liu","year":"2020","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib101","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.it.2022.09.006","article-title":"Neuro-epithelial-ILC2 crosstalk in barrier tissues","volume":"43","author":"Yin","year":"2022","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib102","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1681\/ASN.2010070693","article-title":"IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease","volume":"22","author":"Cao","year":"2011","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib103","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","article-title":"IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis","volume":"111","author":"Hams","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2018.07.002","article-title":"Innate lymphoid cells in organ fibrosis","volume":"42","author":"Mikami","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/path.5092","article-title":"An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis","volume":"245","author":"Zhao","year":"2018","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib106","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib107","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbrc.2016.04.010","article-title":"Upregulation of Interleukin-33 in obstructive renal injury","volume":"473","author":"Chen","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155963","article-title":"IL-33 attenuates renal fibrosis via group2 innate lymphoid cells","volume":"157","author":"Nagashima","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2024.104828","article-title":"Group2 innate lymphoid cells ameliorate renal fibrosis and dysfunction associated with adenine-induced CKD","volume":"401-402","author":"Nagashima","year":"2024","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.07.005_bib110","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.immuni.2024.05.004","article-title":"Intestinal CXCR6(+) ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression","volume":"57","author":"Liang","year":"2024","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib111","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/15353702221147561","article-title":"Reduced type 3 innate lymphoid cells related to worsening kidney function in renal dysfunction","volume":"248","author":"Pan","year":"2023","journal-title":"Exp. Biol. Med. (Maywood N. J. )"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.07.005_bib112","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.ymthe.2022.06.019","article-title":"P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition","volume":"30","author":"Chen","year":"2022","journal-title":"Molecular therapy journal American Society Gene Therapy"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib113","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00018-022-04137-0","article-title":"Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3","volume":"79","author":"Wu","year":"2022","journal-title":"Cell. Mol. life Sci. CMLS"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib114","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14275","article-title":"Macrophage iron dyshomeostasis promotes aging-related renal fibrosis","volume":"23","author":"Wu","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fimmu.2015.00597","article-title":"Macrophage and innate lymphoid cell interplay in the genesis of fibrosis","volume":"6","author":"Hams","year":"2015","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.07.005_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103835","article-title":"New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy","volume":"24","author":"Dang","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib117","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2020.03.002","article-title":"Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA","volume":"52","author":"Satoh-Takayama","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2025.07.005_bib118","article-title":"IL-5-producing group 2 innate lymphoid cells promote t cell-independent IgA production in cooperation with eosinophils","author":"Yanagibashi","year":"2024","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.07.005_bib119","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2021081145","article-title":"Interleukin-33 exacerbates IgA glomerulonephritis in transgenic mice overexpressing b cell activating factor","volume":"33","author":"Wang","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6540937","article-title":"Serum levels of soluble ST2 and IL-10 are associated with disease severity in patients with IgA nephropathy","volume":"2016","author":"Zhang","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"10405","key":"10.1016\/j.cytogfr.2025.07.005_bib121","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(23)01554-4","article-title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","volume":"402","author":"Lafayette","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.07.005_bib122","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.kint.2024.03.012","article-title":"A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy","volume":"105","author":"Lafayette","year":"2024","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.07.005_bib123","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ekir.2022.12.014","article-title":"Randomized phase 2 trial of telitacicept in patients with IgA nephropathy with persistent proteinuria","volume":"8","author":"Lv","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib124","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2305635","article-title":"A phase 2 trial of sibeprenlimab in patients with IgA nephropathy","volume":"390","author":"Mathur","year":"2024","journal-title":"N. Engl. J. Med"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.07.005_bib125","doi-asserted-by":"crossref","first-page":"Itc81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clim.2019.03.008","article-title":"Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus","volume":"202","author":"Guo","year":"2019","journal-title":"Clin. Immunol."},{"issue":"8035","key":"10.1016\/j.cytogfr.2025.07.005_bib127","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41586-024-07907-x","article-title":"Amplification of autoimmune organ damage by NKp46-activated ILC1s","volume":"634","author":"Biniaris-Georgallis","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib128","first-page":"676","article-title":"Innate lymphoid cells are increased in systemic lupus erythematosus","volume":"37","author":"Hou","year":"2019","journal-title":"Clin. Exp. Rheuma"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13075-020-2114-5","article-title":"Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis","volume":"22","author":"Ryu","year":"2020","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109029","article-title":"Imbalance of circulating innate lymphoid cell subpopulations in patients with chronic kidney disease","volume":"239","author":"Wang","year":"2022","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.07.005_bib131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imcb.12842","article-title":"ILC1 as critical gatekeepers in autoimmune kidney damage","volume":"103","author":"Seillet","year":"2025","journal-title":"Immunol. Cell Biol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.07.005_bib132","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41423-024-01178-2","article-title":"The protective roles of integrin \u03b14\u03b27 and Amphiregulin-expressing innate lymphoid cells in lupus nephritis","volume":"21","author":"Ryu","year":"2024","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.07.005_bib133","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41584-024-01140-6","article-title":"Integrin-mediated ILC2 adhesion protects against lupus nephritis","volume":"20","author":"McHugh","year":"2024","journal-title":"Nat. Rev. Rheuma"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.07.005_bib134","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/eji.201747303","article-title":"T cell-derived IFN-\u03b3 downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus","volume":"48","author":"D\u00fcster","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.07.005_bib135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.46497\/ArchRheumatol.2020.7440","article-title":"Imbalanced innate lymphoid cells are associated with disease activity and arthritis involvement in patients with systemic lupus erythematosus","volume":"35","author":"Jiang","year":"2020","journal-title":"Arch. Rheuma"},{"issue":"35","key":"10.1016\/j.cytogfr.2025.07.005_bib136","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302804","article-title":"Group 3 innate lymphoid cells exacerbate lupus nephritis by promoting b cell activation in kidney ectopic lymphoid structures","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.07.005_bib137","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/sji.12637","article-title":"Activity of group 2 innate lymphoid cells is associated with chronic inflammation and dysregulated metabolic homoeostasis in type 2 diabetic nephropathy","volume":"87","author":"Lu","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib138","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8512028","article-title":"Group 2 innate lymphoid cells participate in renal fibrosis in diabetic kidney disease partly via TGF-\u03b21 signal pathway","volume":"2019","author":"Liu","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.07.005_bib139","first-page":"820","article-title":"Enhanced ILC2 activity contributes to metabolic syndrome multicomponent aggregation state in patients with type 2 diabetic nephropathy","volume":"33","author":"Lu","year":"2017","journal-title":"Xi bao yu Fen. zi mian yi xue za zhi = Chin. J. Cell. Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2025.07.005_bib140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3389\/fphar.2019.00572","article-title":"Novel immunomodulatory cytokine regulates inflammation, diabetes, and obesity to protect from diabetic nephropathy","volume":"10","author":"Sabapathy","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.07.005_bib141","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/rheumatology\/kez116","article-title":"Increased expression of fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"58","author":"Blokland","year":"2019","journal-title":"Rheumatology"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:52:18Z","timestamp":1772884338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610125000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":141,"alternative-id":["S1359610125000875"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.07.005","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of innate lymphoid cells in kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}